![James Schenck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
James Raymond Schenck currently works at Citadel Securities LLC, as Senior Investment Associate from 2024.
Mr. Schenck also formerly worked at HealthCor Management LP, as Investor from 2022 to 2023 and Catalio Capital Management LP (Investment Management), as Analyst from 2023 to 2024.
Postes actifs de James Schenck
| Sociétés | Poste | Début |
|---|---|---|
Citadel Securities LLC
 Citadel Securities LLC Investment Banks/BrokersFinance Provides securities brokerage services | Analyst-Equity | 01/11/2024 |
Anciens postes connus de James Schenck
| Sociétés | Poste | Fin |
|---|---|---|
Catalio Capital Management LP (Investment Management)
 Catalio Capital Management LP (Investment Management) Investment ManagersFinance Catalio-IM aims to produce extraordinary returns by creating and sustaining life sciences companies that combine the best science and technology with the best management and execution. The firm’s public equities strategy is a long bias, fundamental, bottoms-up equity long/short strategy that invests in global healthcare equities across sectors: innovative drugs, devices, diagnostics and data. The strategy’s investment style is a “best idea” orientation focused on identifying mis-priced risk in clinical, regulatory, intellectual property, manufacturing, commercial, and management. | Corporate Officer/Principal | 01/11/2024 |
HealthCor Management LP
 HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Gestionnaire de Portefeuille-Actions | 01/01/2023 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
HealthCor Management LP
HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Finance |
Citadel Securities LLC
Citadel Securities LLC Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Catalio Capital Management LP (Investment Management)
Catalio Capital Management LP (Investment Management) Investment ManagersFinance Catalio-IM aims to produce extraordinary returns by creating and sustaining life sciences companies that combine the best science and technology with the best management and execution. The firm’s public equities strategy is a long bias, fundamental, bottoms-up equity long/short strategy that invests in global healthcare equities across sectors: innovative drugs, devices, diagnostics and data. The strategy’s investment style is a “best idea” orientation focused on identifying mis-priced risk in clinical, regulatory, intellectual property, manufacturing, commercial, and management. | Finance |
